Neil Nixon
Overview
Explore the profile of Neil Nixon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
83
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Patel S, Patel P, Boutry C, Guo B, Butler D, Higton F, et al.
Trials
. 2025 Feb;
26(1):62.
PMID: 39980028
Background: Randomised controlled trials (RCTs) are widely regarded as the most powerful research design for evidence-based practice. However, recruiting to RCTs can be challenging resulting in heightened costs and delays...
2.
Hawsawi A, Nixon N, Nixon E
PLoS One
. 2025 Feb;
20(2):e0318399.
PMID: 39913638
Background And Aims: In recent years, increased awareness of the psychological wellbeing of healthcare professionals and students has become a pressing public health issue affecting care delivery. Medical students undergo...
3.
Mavranezouli I, Megnin-Viggars O, Pedder H, Welton N, Dias S, Watkins E, et al.
EClinicalMedicine
. 2024 Sep;
75:102780.
PMID: 39246718
Background: Various effective treatments for depression exist. We aimed to identify the most effective first-line treatments for new episodes of less and more severe depression (defined by depression scale cut-off...
4.
Hawsawi A, Nixon N, Stewart E, Nixon E
BMC Med Educ
. 2024 Jun;
24(1):671.
PMID: 38886747
Background: Medical students have reported facing unique challenges in their academic journey that can have a significant impact on their mental health and wellbeing; therefore, their access to support services...
5.
Nixon N, Guo B, Kaylor-Hughes C, Simpson S, Garland A, Dalgleish T, et al.
J Affect Disord
. 2023 Oct;
345:70-77.
PMID: 37863366
Background: Despite the known health costs of persistent depression, there is no established service framework for the treatment of this disorder and a lack of long-term outcome data to inform...
6.
Morriss R, Patel S, Boutry C, Patel P, Guo B, Briley P, et al.
Lancet Psychiatry
. 2023 Feb;
10(3):172-183.
PMID: 36724796
Background: Randomised sham-controlled trials of cranial electrostimulation with the Alpha-Stim Anxiety Insomnia and Depression (AID) device have reported improved anxiety and depression symptoms; however, no adequately powered sham-controlled trials in...
7.
Patel S, Boutry C, Patel P, Craven M, Guo B, Zafar A, et al.
Trials
. 2022 Apr;
23(1):250.
PMID: 35379314
Background: Major depression is the second leading cause of years lost to disability worldwide and is a leading contributor to suicide. However, first-line antidepressants are only fully effective for 33%,...
8.
Lipschitz J, Connolly S, Van Boxtel R, Potter J, Nixon N, Bidargaddi N
Psychol Serv
. 2022 Feb;
20(Suppl 2):11-19.
PMID: 35201809
After years of slow and fragmented implementation of telemental health (TMH), the coronavirus disease (COVID-19) pandemic necessitated widespread adoption. With the initial state of public health emergency behind us, we...
9.
Bakolis I, Stewart R, Baldwin D, Beenstock J, Bibby P, Broadbent M, et al.
BMJ Open
. 2021 May;
11(5):e049721.
PMID: 34039579
Objectives: To investigate changes in daily mental health (MH) service use and mortality in response to the introduction and the lifting of the COVID-19 'lockdown' policy in Spring 2020. Design:...
10.
Nixon N, Guo B, Garland A, Kaylor-Hughes C, Nixon E, Morriss R
PLoS One
. 2020 Oct;
15(10):e0241370.
PMID: 33104761
Background: The 17-item Hamilton Depression Rating Scale (HDRS17) is used world-wide as an observer-rated measure of depression in randomised controlled trials (RCTs) despite continued uncertainty regarding its factor structure. This...